Molecular endocrinology (Baltimore, Md.)

Stable protein made from Rev-erbalpha2 mRNA may help control the body’s daily biological clock

Updated

Abstract

REV-ERBalpha1 is expressed one to 100 times more than REV-ERBalpha2, depending on tissue and circadian time.

  • Circadian rhythms are regulated by a complex network involving transcriptional loops and posttranslational modifications.
  • REV-ERBalpha plays a critical role in the circadian clock, with its expression oscillating on a 24-hour cycle.
  • Two protein variants of REV-ERBalpha, REV-ERBalpha1 and -alpha2, have been identified, with distinct biological functions.
  • REV-ERBalpha2 has a half-life that is incompatible with circadian function, suggesting it may not participate in the same regulatory processes as REV-ERBalpha1.
  • Both variants exhibit similar DNA-binding properties and transcriptional repression activities, indicating a conserved regulatory mechanism.
  • The turnover of REV-ERBalpha2 decreases when coexpressed with REV-ERBalpha1, suggesting that their relative expression levels influence circadian period length.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free